Apteryx Imaging Inc. announced that it had partnered with Lucerne-based 4th IR AG to co-develop cloud-based AI solutions for digital imaging in dentistry. 4th IR has now completed the Caries Module, which is intended to be an AI decision support module for use with Apteryx's existing software platforms and as a standalone product for the general dental market. Under the software development agreement between Apteryx Inc. and 4th IR, Apteryx has agreed, in addition to certain cash payments, to issue 4th IR a payment of USD 50,000 upon acceptance of the Caries Module, which will be paid in common shares of Apteryx issued at a share price of CAD 0.40 per share. 4th IR is also developing a Quality Assurance Module, which is intended to be an AI module to assist in the identification of image related quality issues for use with Apteryx's existing software platforms and as a standalone product for the general dental market. Under the software development agreement, Apteryx has agreed, in addition to certain cash payments, to issue 4th IR a payment of USD 50,000 upon acceptance of the Quality Assurance Module, which will be paid in common shares of Apteryx issued at a share price of the lesser of CAD 0.40 and the current market price. Under the software development agreement, Apteryx owns all source code and intellectual property rights to the work product. The commercialization of the modules will be subject to regulatory approval, which may include approvals of the U.S. Food and Drug Administration and other government regulators.